$AMRS, BIOSSANCE(TM) to Launch in Sephora Stores 20

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz
$AMRS,

BIOSSANCE(TM) to Launch in Sephora Stores
20 minutes ago - DJNF
BIOSSANCE(TM) to Launch in Sephora Stores

Fast Growing, Sustainable Skin Care Brand Partners with Leading Prestige Specialty Beauty Retailer to Meet Growing Consumer Demand for Sustainable Skin Care Products

EMERYVILLE, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Biossance(TM), the consumer beauty brand from Amyris, Inc. (NASDAQ:AMRS), today announced its planned launch in Sephora's retail stores where the brand's expansive line of high-performance skin care products will be available to consumers. The rollout to initial participating stores will begin in February 2017 and coincide with launching on Sephora online. Additional in-store and online marketing activities with Sephora to highlight the Biossance brand shortly following launch are planned.

"We are excited to launch with Sephora in the coming months and look forward to a strong partnership with them in the years to come. We expect this partnership combined with our strong growth will more than double our revenue in 2017," said Caroline Hadfield, Senior Vice President, Personal Care, at Amyris. "Amyris and Sephora share similar philosophies when it comes to innovation, sustainability, and responsibility while providing efficacious products and we are delighted by their support of our brand."

Sephora is the leading specialty beauty retailer globally, teaching and inspiring clients to play in a world of beauty. Sephora has earned its reputation with its expertise, innovation, and entrepreneurial spirit, and has been changing the face of prestige cosmetics since its debut in Paris in the early 1970's. Now with more than 2,300 stores in 33 countries - including more than 500 stores across North America - plus an award-winning website and an intuitive mobile app, clients have the opportunity to discover 14,000 products from 200 carefully curated brands anytime, anywhere, anyhow.

About Biossance

Biossance uses innovative biotechnology to create skincare products that are incredibly effective, sustainable and safe. In its Berkeley-born labs 100% plant-based squalane was created sustainably from sugarcane. Biossance formulates with a No Compromise(TM) approach, proudly blacklisting over 2,000 ingredients that are potentially harmful to you or the planet. Pioneering sustainable beauty through biotechnology, Biossance makes sure only the most trustworthy and powerful ingredients make the final cut. The full Biossance skin care and beauty collection can be found at www.Biossance.com.

About Amyris

Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise(R) products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, and pharmaceuticals and nutraceuticals. More information about the company is available at www.amyris.com.

Forward-Looking Statements

This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as the company's projection that the partnership combined with Amyris's strong growth will more than double revenue in 2017) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to manufacturing capacity at Amyris's Brotas facility, delays or failures in development, production and commercialization of products, liquidity and ability to fund capital expenditures, Amyris's reliance on third parties to achieve its goals, and other risks detailed in the "Risk Factors" section of Amyris's quarterly report on Form 10-Q filed on August 9, 2016. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

Amyris, the Amyris logo, and Biossance are trademarks or registered trademarks of Amyris, Inc. All other trademarks are the property of their respective owners.

Media Contacts

Elle Communications

Megan Noller

+1 (424)634-8370

Megan@ellecomm.com

Peter DeNardo

Director, Investor Relations and Corporate Communications

Amyris, Inc.

+1 (510) 740-7481

investor@amyris.com

pr@amyris.com

(MORE TO FOLLOW) Dow Jones Newswires

October 31, 2016 08:30 ET (12:30 GMT)
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 398

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Innovative CORDStrom™ Platform by INmune Bio

Updated Category News Views 200

Introduction to CORDStrom™ and Its Significance INmune Bio, Inc. (NASDAQ: INMB), a pioneer in the field of inflammation and immunology therapies, has recently sparked significant interest in the medical community. Their intriguing CORDStrom™ platform signifies a promising advance in mesenchymal stromal cell (MSC) therapies, aiming to address various health conditions...

Continue Reading
Brooklyn Law School Enhances Scholarship Support for Veterans

Updated Category News Views 156

Brooklyn Law School Expands Support for Veteran Students Brooklyn Law School has taken significant steps to demonstrate its commitment to veterans by increasing scholarship support, ensuring they receive the assistance they need to excel in their legal education. This initiative reflects a profound recognition of the sacrifices made by our armed forces members and aims to...

Continue Reading
Unlocking Creativity with the New vivo X200 FE Smartphone

Updated Category News Views 441

Introducing the vivo X200 FE: Ideal for the Innovative Generation Vivo proudly announces the launch of the X200 FE, a cutting-edge smartphone designed with the vibrant essence of the new generation in mind. This model combines playful aesthetics with dependable functionality, delivering an exceptional user experience. With its striking color-blocking design and advanced...

Continue Reading
Exploring Market Sentiment Towards Westinghouse Air Brake Tech

Updated Category News Views 201

Current Sentiment Around Westinghouse Air Brake Technologies Corp Westinghouse Air Brake Technologies Corp (NYSE: WAB) is a prominent player in the transportation industry, particularly known for its innovation in braking systems and other technology. Recently, it has come to light that the short interest as a percentage of its float has decreased significantly, by...

Continue Reading
Asante Gold Highlights Shareholder Meeting Information and Voting

Updated Category News Views 165

Key Information about Asante Gold's Upcoming Shareholder Meeting Your participation is crucial, regardless of how many shares you own in Asante Gold. The Company’s Board of Directors strongly advises all shareholders to vote for all resolutions presented. Proxy Materials Available Online Asante Gold Corporation (TSXV: ASE | GSE: ASG | OTCQX: ASGOF) has announced that...

Continue Reading